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Abstract 
Does Weight Matter? 
Prospective Examination of Premorbid Body Weight as a Predictor of Eating Pathology 
Alexandra F. Muratore 
 
Despite years of research on eating disorders, their persisting prevalence suggests limited 
efficacy of current prevention efforts and establishes the need for the identification of 
additional risk and maintenance factors. Predominant conceptualizations of eating 
disorders have placed continued emphasis on psychosocial factors associated with eating 
pathology. As such, the role of actual body weight has received limited attention, and 
relevant relationships between these factors and eating disorder development remain 
elusive. Preliminary evidence has identified elevated premorbid body weights in eating 
disorder patients, suggesting that these individuals may be biologically predisposed to 
higher weights and that this predisposition may be a factor relevant to subsequent eating 
disorder development. The current study sought to examine whether higher premorbid 
body weights prospectively predict subsequent clinical status in a sample of female eating 
disorder inpatients. By examining body weight in relation to subsequent symptom 
severity, the current study sought to establish premorbid body weight as a factor relevant 
to the development of eating pathology. Results indicated a significant relationship 
between highest premorbid z-BMI and self-reported Eating Concerns at treatment intake, 
though this relationship was not significant when accounting for current BMI. There was 
also a marginally significant interaction between premorbid z-BMI and current weight, 
such that those with a higher current BMI and a history of relatively lower highest 
premorbid z-BMI exhibited the greatest eating and weight concerns. These finding 
vi 
 
suggest  a potential combined influence of current and historical weight in the role of 
Eating and Weight concerns. 
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Chapter 1: Introduction 
1.1. Traditional Conceptualizations of Eating Disorders 
 
Despite years of research and treatment development, eating disorders remain a 
fundamental problem that affects a significant number of individuals each year. A review 
of lifetime prevalence rates of eating disorder subtypes in the U.S. alone suggests 
anywhere from 0.9%-3.5% of females will develop an eating disorder, including anorexia 
nervosa (AN, 0.9%) bulimia nervosa (BN, 0.9-1.5%), binge-eating disorder (BED, 3.5%) 
and other specified feeding or eating disorders (OSFED) (Smink, van Hoeken, & Hoek, 
2012). Importantly, these statistics do not include males, adolescents, or individuals in 
non-U.S. countries, among whom lifetime prevalence rates of eating disorders are also 
significant. Perhaps more concerning is the heightened mortality rates identified across 
all eating disorders, particularly AN (Smink et al., 2012). The persisting prevalence of 
eating disorders underscores the limited efficacy of current prevention efforts, and 
demonstrates the continuing need to identify etiological factors associated with disorder 
onset. Indeed, identifying predictors of eating disorder development will not only aid in 
prevention efforts but may also be integrated into current treatment protocols, which 
themselves remain in relatively rudimentary stages of development. As such, the 
mechanisms underlying eating disordered behaviors demand increased attention to assist 
in the development of more effective preventative efforts and treatment protocols.  
Eating disorder symptoms span a range of dysfunctional behaviors which may 
include abnormal eating patterns, compensatory behaviors, or other weight and eating-
related rituals. Though the symptom profile comprising an eating disorder varies based 
on diagnosis, there exists some overlap and crossover between disorders (Tozzi et al., 
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2005; Vervaet, van Heeringen, & Audenaert, 2004). At present, the most widely-accepted 
model for conceptualization and treatment of eating disorders is the recent enhanced 
cognitive-behavioral therapy (CBT-E), as introduced by Fairburn and colleagues 
(Fairburn, Cooper, & Shafran, 2003). The CBT-E model stresses the trans-diagnostic 
cognitive mechanisms identified in a number of eating disorders, particularly the 
overvaluation of shape and weight as the core psychopathology of the disorder. While the 
original CBT model identified this trait in BN, the enhanced model extends this cognitive 
trait to all diagnostic subtypes, including AN, BED and OSFED. The CBT-E model holds 
that this overvaluation leads to extreme food restriction, checking-behaviors, and other 
related rituals driven by preoccupation with shape, weight, or control. These restrictive 
behaviors often lead to disinhibition of food intake and subsequent binge-eating 
behaviors, which are characterized by eating an objectively or subjectively large amount 
of food, combined with a strong feeling of loss of control over food consumption.  
Cognitive-behavioral and other predominant models conceptualizing eating 
disorders have thus far focused primarily on the maintenance of eating disorders. 
Moreover, current research places continued emphasis on affective, cognitive and social 
mechanisms underlying eating disorder symptoms. Indeed, an extensive body of research 
has investigated the relationship between eating disorders and negative affect 
(Lingswiler, Crowther, & Stephens, 1989; Macht, 2008; Stein et al., 2007)(Lingswiler et 
al., 1989), inhibitory control (Herman & Polivy, 1988; Wu et al., 2013), interoceptive 
awareness (Engler, Crowther, Dalton, & Sanftner, 2006; Garner, Olmsted, Polivy, & 
Garfinkel, 1984) and cognitive flexibility, such as set-shifting (Roberts, Tchanturia, 
Stahl, Southgate, & Treasure, 2007). Other frequently examined constructs include body 
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dissatisfaction, drive for thinness, and self-esteem (Ramacciotti et al., 2001; Stice, South, 
& Shaw, 2012; Wade & Tiggemann, 2013; Williams et al., 1993).  
While existing research has provided an extensive and critical foundation toward 
a better understanding of eating disorder development and maintenance, research over the 
past several decades has largely overlooked the significance of body size and its role in 
eating disorder development and trajectory. Interestingly, the role of body weight in 
eating disorder development is not a novel concept; it was initially introduced by Russell 
(1979), who addressed the potential role of elevated body weight and subsequent weight 
loss in the development of BN. Despite this, the overwhelming majority of both clinical 
and research work have continued to focus primarily on psychological constructs, such as 
body image, while overlooking actual body weight. However, actual body weight 
arguably influences one’s body image, satisfaction, and subsequent behavior. For 
example, it is likely that an eating disorder patient who fears weight gain toward a 
previous high weight will experience increased distress at elevated weights and may alter 
behavior to initiate desired weight loss. Indeed, the absence of body weight as a construct 
in the literature hinders a more multi-dimensional understanding of the potential 
relationship between historical body weight and risk for eating disorder development.  
1.2. The Role of Body Weight in Eating Disorders: A Review of Current 
Literature 
 
 Given that psychological constructs associated with body weight have been 
implicated in eating disorders, it becomes necessary to identify and clarify the distinction 
between the weight-related (e.g., actual body mass and change in body mass) and 
psychological (e.g., perception and negative evaluation of body mass) components of 
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body weight and their respective implications.  Thus far, associations between body 
weight and eating disorders have been examined in terms of weight history (e.g., 
premorbid body weights) and weight after disorder development (e.g., current body 
weight at time an individual is assessed, and weight suppression, or the difference 
between highest historical weight and current body weight). A review of preliminary 
findings related to each construct is presented below.  
1.2.1. Weight History 
Evidence of a Predisposition to Higher Weights 
 
Current literature suggests eating disorder patients may have a susceptibility to 
elevated weights before disorder development. Indeed, elevated body mass index (BMI) 
has been identified in both AN and BN patients premorbidly. For example, early research 
on AN suggests a substantial portion of female patients are premorbidly overweight or 
obese when compared with matched population mean weight (Crisp, Hsu, Harding, & 
Hartshorn, 1980; Crisp & Stonehill, 1971). In one sample, 46.2% of patients were 
premorbidly overweight (Crisp & Stonehill, 1971). A subsequent study of 102 patients 
reported that patients were on average slightly overweight premorbidly, and that 28% of 
these patients were premorbidly obese (Crisp et al., 1980). More recent research also 
provides support for the notion that a substantial proportion of eating disorder patients are 
premorbidly obese: a survey of eating disorder inpatients found a high prevalence of 
lifetime obesity, ranging from 4.6-28.8% across eating disorder subgroups (Villarejo et 
al., 2012). Similarly, another investigation of AN-BP, AN-R and OSFED patients 
reported premorbid obesity in 20% of patients (Wojciechowska, Garland, & 
Hergenroeder, 2013). Consistent with this notion, research on males with eating disorders 
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suggests these patients are more likely to be premorbidly obese, with 45-60% of patients 
being premorbidly overweight (Carlat, Camargo, & Herzog, 1997; Jasik, Breland, & 
Buckelew, 2010),  further providing support for the notion that eating disorder patients 
may be inherently susceptible to higher weights.  
It should be noted that the origins of elevated premorbid weights remain unclear. 
The prevalence of premorbid overweight and obesity in these samples could reflect a 
hereditary predisposition or deviation from normal weight trajectory during development 
occurring for non-genetic reasons. Current findings suggest both hereditary and 
developmental influences may be at play. Parental obesity has been associated with 
offspring eating disorder diagnoses (Fairburn, Cooper, Doll, & Welch, 1999; Garfinkel, 
Moldofsky, & Garner, 1980; Shaw et al., 2012); given that BMI is a highly heritable trait 
(Elks et al., 2012), offspring of obese parents may therefore be susceptible to elevated 
weights. An examination of premorbid weight in the years prior to eating disorder onset 
identified a pattern of weight gain prior to weight loss (Swenne, 2001). Moreover, the 
majority of patients (87%) gained weight quickly and at a higher than average rate before 
reaching their maximum premorbid weight and developing a disorder, suggesting that 
premorbid deviation from normative growth may also contribute to higher rates of 
overweight and obesity in these samples. 
Taken together, these findings suggest that elevated weights in premorbid states 
may be relevant to eating disorder development. However, at present, the means by 
which these elevated premorbid weights may confer risk for eating disorder development 
and maintenance remain uncertain. Higher weights could contribute to different 
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symptoms such as increased psychological distress (e.g., higher body dissatisfaction), 
weight loss behaviors (e.g., more intensive dieting or food restriction), or both.  
Premorbid Weight and Clinical Presentation 
 
Research on the relationship between premorbid body weight and symptom 
development remains nascent, though preliminary research suggests associations between 
elevated premorbid weights and clinical outcome. Lifetime obesity across all eating 
disorder subtypes has been associated with increased eating disorder severity (Villarejo et 
al., 2012). Moreover, high premorbid weights may be relevant to the development of 
specific eating disordered symptoms, including binge/purge symptoms and restrictive 
pathologies. For example, initial research found binge-purge subtypes of AN patients 
(AN-BP) were more likely to report elevated premorbid BMIs than restrictive subtypes of 
AN (AN-R), suggesting that weights may be particularly elevated among patients with 
binge-purge symptoms (Garfinkel et al., 1980).  
However, more recent research suggests that elevated premorbid weight may be 
associated with restrictive symptoms as well: an examination of both AN and atypical 
AN patients (those who exhibited AN symptoms and weight loss but remained in a 
normal or above average weight range) found both greater symptom severity, including 
Restraint, Eating, Shape and Weight concerns, and a greater rate of elevated premorbid 
BMIs among the atypical AN group (71%) than among the AN group (12%) (Sawyer, 
Whitelaw, Le Grange, Yeo, & Hughes, 2016). Because the atypical AN group was also 
higher in current BMI than the AN group, it is difficult to discern whether differences in 
symptom severity were due to current or premorbid weights. In another study examining 
male eating disorder patients, a history of overweight or obesity was associated 
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specifically with reduced dietary intake and increased compensatory behaviors (Jasik et 
al., 2010). Elevated weights may therefore be relevant to both symptom profile and 
clinical severity.  
Among AN patients, elevated premorbid body weight levels also predict 
increased amount of weight lost prior to treatment referral and reduced energy intake 
throughout treatment (Coners, Remschmidt, & Hebebrand, 1999; Shinder & Shephard, 
1993).  The notion that AN patients with higher premorbid body weights consumed less 
during treatment suggests that even after such substantial weight loss, these individuals 
engaged in more active attempts to avoid returning to these higher weights. This finding 
suggests another reason why highest premorbid weight reached may be important to 
examine in relation to later eating disorder characteristics.  
Taken together, a history of elevated weights among eating disorder patients 
suggests these individuals carry a biological predisposition toward higher weights.  
Consistent with the notion that higher weights could promote increased eating disorder 
behaviors, higher rates of premorbid elevated weight among certain eating disorder 
subgroups suggest that a predisposition toward higher weights may be associated with 
clinical presentation spanning a range of symptoms, including binge/purge and restrictive 
symptoms. These findings imply not only a significant relationship between elevated 
body weight and eating disorder risk and maintenance, but also suggest that premorbid 
body weight may be relevant to subsequent symptom development and clinical outcome. 
Indeed, continued body dissatisfaction and constant effort required to avoid returning to 
previous higher weights could serve to perpetuate an eating disorder.  While certain 
eating disorder subgroups have exhibited a greater predisposition toward higher 
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premorbid weights, the extent to which premorbid body weight per se influences specific 
eating disorder symptoms has not yet been explored. As such, the relationship between 
premorbid predisposition toward higher weights and subsequent clinical presentation 
warrants additional consideration as a factor in eating disorder development and 
maintenance. 
1.2.2.  Weight After Disorder Development 
 
In addition to potential relationships between premorbid BMI and eating disorder 
etiology, individuals’ weight after development of an eating disorder (i.e., current weight 
status, including current body weight and weight relative to premorbid levels) may also 
carry clinical significance.  
Current Weight 
  The relatively persistent nature of BMI suggests that a premorbid predisposition 
to higher weights may persist after eating disorder onset. Despite varying amounts of 
weight loss between individuals, there remains a strong correlation between an 
individual’s premorbid weight and subsequent weights throughout an eating disorder; the 
correlation between body weights across time despite significant weight fluctuation has 
been referred to as BMI “tracking” (Carter, McIntosh, Joyce, Gendall, & Bulik, 2004; 
Coners et al., 1999; Föcker et al., 2014; Miyasaka et al., 2003; Steinhausen, Grigoroiu-
Serbanescu, Boyadjieva, Neumarker, & Metzke, 2009). Indeed, premorbid body weights 
have been linked to subsequent weight throughout disorder development, maintenance 
and outcome. For example, Shaw et al. (2012) examined pre- and post-morbid BMI 
levels in BN patients and found that in addition to reporting elevated premorbid BMIs, 
the majority of patients reached their highest BMI after the onset of the disorder. This 
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finding further suggests that eating disorder patients may be initially predisposed to 
higher weights premorbidly and that this biological predisposition may continue to 
manifest itself after eating disorder onset. As such, one may continue to exhibit this 
predisposition throughout the lifespan, and may need to exert continued effort to 
counteract biological drives toward weight gain. 
Current Weight and Clinical Presentation 
Much of the research on weight after disorder development includes 
measurements of body weight before treatment (i.e., at referral), during treatment, and 
after treatment (i.e., at follow-up). Current findings suggest that one’s current weight, as 
assessed at any of these time points, may be relevant to clinical presentation and 
outcome. For example, BN patients who gained weight at a 5-year follow-up were more 
likely to have higher BMIs and greater body dissatisfaction at pre-treatment, post-
treatment, and follow-up (Carter, McIntosh, Joyce, Gendall, Frampton, et al., 2004). 
These findings not only support the notion of BMI tracking, but also indicate greater 
body dissatisfaction with higher weights across a series of time-points.  
Similarly, among AN patients, lower BMIs at treatment referral were associated 
with lower depression scores (Miyasaka et al., 2003). The authors of this research suggest 
that lower depression scores among AN patients with lower BMIs may be attributed to 
greater satisfaction with low body weights, further implicating the interpretation of and 
satisfaction with current weight as a potential maintenance factor for eating disorders. 
This particular finding is interesting to consider in light of the fact that higher premorbid 
body weights have previously been associated with lower BMIs at treatment referral in 
AN patients (Coners et al., 1999; Shinder & Shephard, 1993). Specifically, it could 
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reasonably be theorized that the more weight AN patients lose, the greater their 
psychological investment in maintaining a lower weight. Taken together, these findings 
suggest that AN patients with higher premorbid BMIs not only lose more weight 
(presenting with lower BMIs at referral), but have increased satisfaction with their weight 
loss (indicated by lower depression scores) and subsequently increase their efforts to 
maintain their weight loss and prevent weight gain (as evidenced by reduced energy 
intake throughout treatment), thereby perpetuating the disorder. 
  Lower BMI at referral has also been associated with poorer long-term outcomes, 
including chronic AN and death by emaciation, while those with higher percentage of 
average body weight at intake have demonstrated faster time to both partial and full 
recovery (Chakraborty & Basu, 2010; Hebebrand et al., 1997). Consistent with these 
findings, AN patients with low BMIs at post-treatment follow up exhibited significantly 
poorer outcomes, characterized by greater eating pathology, lower psychosocial 
development, and lower total functioning (Steinhausen et al., 2009). These findings 
thereby implicate current body weight as a factor of importance in the symptoms 
associated with eating disorders as well.  
Weight Suppression 
 
Current weight relative to prior weights may also be relevant to consider: eating 
disorder development represents a departure from premorbid BMI levels, usually 
characterized by weight loss, which may carry biological and psychological implications. 
For example, major weight loss is known to reduce metabolic rate, thereby slowing one’s 
energy expenditure and promoting the likelihood of weight gain (Stice, Durant, Burger, 
& Schoeller, 2011). Weight loss has also been associated with increased binge-eating 
11 
 
behavior, which is likely to have similar effects on weight (Lowe, Thomas, Safer, & 
Butryn, 2007). The biological and psychological correlates of weight loss may therefore 
serve to promote weight gain. This is undoubtedly distressing to eating disordered 
individuals and is likely met with increased attempts to control or prevent this weight 
gain, in turn perpetuating maintenance of one’s disorder. Indeed, this cycle of symptom 
maintenance may in part explain the persistent nature of eating disorders. Moreover, 
one’s opinion of their current body weight (e.g., if one’s body weight falls within the 
normal weight range but is heavier than their ideal weight, they may deem their current 
weight unacceptable) may contribute to body dissatisfaction and subsequent weight loss 
behaviors, further influencing disorder trajectory.  One construct frequently used to 
assess the discrepancy between premorbid body weights and current body weight is 
weight suppression (WS), or the difference between one’s current weight and highest-
ever adult weight (Lowe, 1993). A number of studies have identified heightened levels of 
WS in BN patients, and mean rates of WS in BN patients are reportedly higher than mean 
rates of healthy adults (Butryn, Juarascio, & Lowe, 2011; Butryn, Lowe, Safer, & Agras, 
2006; Keel & Heatherton, 2010; Lowe, 1993; Lowe, Annunziato, et al., 2006; Lowe, 
Davis, Lucks, Annunziato, & Butryn, 2006). Studies of BN patients have reported WS 
means ranging from 9.4-12.0 kg, (20.7-26.4 lbs) compared to healthy college-aged 
individuals with a reported mean WS of approximately 2.7 kg (5.6 lbs) (Butryn et al., 
2011; Butryn et al., 2006; Lowe, Annunziato, et al., 2006; Lowe, Davis, et al., 2006). 
The notion that WS is higher in patient populations as compared to healthy 
controls suggests that current weight status relative to premorbid weight may be a 
clinically relevant construct. Consistent with this notion, current research suggests that 
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higher levels of WS could carry both weight and clinical implications among eating 
disorder patients. 
Indeed, research suggests WS is associated with weight change in eating 
disordered individuals, and has been found to be a robust predictor of weight gain 
(Carter, McIntosh, Joyce, & Bulik, 2008; Wildes & Marcus, 2012). Among BN patients, 
higher levels of WS have been shown to predict weight gain over the course of treatment 
(Carter et al., 2008; Herzog et al., 2010; Lowe, Davis, et al., 2006). Similar findings have 
implicated WS as a predictor of weight gain in AN patients, with greater WS predicting 
both greater total weight gain and a faster rate of weight gain throughout treatment 
(Wildes & Marcus, 2012). Moreover, research indicates that WS and BMI may function 
independently of one another and may be uniquely associated with weight change. For 
example, WS has been shown to interact with BMI in AN patients to predict weight 
related outcomes: Witt et al. (2014) identified a relationship between WS and BMI at 
lowest weight, such that WS predicted the most weight gain among those with the lowest 
BMIs. These findings highlight an important interplay between current weight (e.g., 
BMI) and current weight relative to past weight (e.g., WS), and suggest that both the 
magnitude of weight lost throughout eating disorder development and current weight 
influence eating disorder patients’ subsequent weight trajectory in both AN and BN 
patients.    
Weight Suppression and Clinical Presentation 
 
Given that the biological and behavioral effects of WS may intensify one’s 
tendency to return to, if not exceed, their highest past weights, WS may also be relevant 
to eating pathology. Research on the relationship between WS and eating disorder 
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symptoms suggests WS may be associated with eating disorder development, 
maintenance and outcome.  
Indeed, findings suggest WS may function as a predictor of eating pathology: one 
study examining WS in college samples found WS to predict the onset of a BN syndrome 
at 10-year follow-up (Keel & Heatherton, 2010; Lowe, 1993). WS has also been 
implicated as a maintenance factor for eating disorders. For example, Keel and 
Heatherton (2010) found greater WS to predict maintenance of symptoms at 10-year 
follow-up. WS has also been shown to predict bulimic symptoms throughout treatment in 
both BN and AN patients (Butryn et al., 2006; Wildes & Marcus, 2012). Associations 
between higher WS in AN patients and bulimic symptoms is consistent with findings of 
Garfinkel et al. (1980), and further suggest that predisposition to elevated body weight 
(as evidenced by higher premorbid BMI or greater WS) may be a risk factor for 
diagnostic cross-over (Wildes & Marcus, 2012).  
Finally, WS has been implicated in treatment response and outcome. For example, 
WS has been shown to interact with BMI to predict eating pathology-related outcomes at 
treatment discharge, such that high WS at admission predicted increased symptom 
severity among those with high BMIs, and decreased symptom severity among those with 
lower BMIs (Berner, Shaw, Witt, & Lowe, 2013). These findings suggest that the further 
one is from their highest past weight, the stronger the tendency to return toward it, in turn 
promoting increased attempts to stave off weight gain with maladaptive eating patterns. 
Similarly, among BN patients receiving CBT, higher WS was associated with treatment 
drop-out and greater BN symptomatology among treatment completers (Butryn et al., 
2006). However, a number of other studies designed to replicate these findings found no 
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associations between WS and CBT treatment completion, outcome, or change in BN 
symptoms (Carter et al., 2008; Dawkins, Watson, Egan, & Kane, 2013; Zunker et al., 
2011), though these differences could be due to differential magnitude of WS across 
studies.      
1.3. Summary 
 
  Because the majority of research on eating disorders emphasizes the cognitive, 
affective, and social mechanisms of eating pathology, the role of actual body weight has 
received relatively scant attention. However, findings suggest that eating disordered 
individuals may be in a constant and losing battle against biological drives toward weight 
gain. Evidence of such a predisposition may begin premorbidly, either through hereditary 
or developmental means, and may first be met with attempts to lose weight. The effects 
of weight loss and WS may call on biological drives to re-initiate weight gain, leaving 
eating disordered patients at the mercy of their eating disorder symptoms to counter these 
drives. Therefore, it is possible that weight history may place and hold eating disorder 
patients at pervasive risk for higher weights throughout the lifespan, and may thereby be 
relevant to eating disorder symptom development and outcome. However,  the means by 
which premorbid weights may influence clinical outcome remains largely unexplored and 
is therefore an important target for future research.  
1.4. The Proposed Study 
 
While body weight has been established as a construct that warrants further 
attention, the research thus far has primarily examined highest body weights in adulthood 
or after disorder development, making it difficult to establish the origins of abnormal 
weight trajectories. Moreover, the collection of premorbid body weights thus far has 
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largely relied on retrospective self-report, and may therefore be prone to error. 
Furthermore, extant literature on body weight and symptom severity has examined only 
certain subgroups of eating disorder patients, such as AN or BN; research has yet to 
directly examine premorbid body weights and clinical presentation across all eating 
disorder diagnoses. As such, access to records of both premorbid body weight 
measurements throughout childhood and current measures of symptom severity is 
necessary to identify differential weight patterns and to facilitate a deeper understanding 
of the relevance of premorbid body weight to eating disorder development and symptom 
severity.  
The Renfrew Center is a treatment facility equipped to treat female patients of all 
eating disorder diagnoses in both inpatient and outpatient settings. Importantly, Renfrew 
requests medical growth charts from all of its patients 23 year olds and younger, and from 
certain older patients to clarify individual weight goals; these growth charts therefore 
include a series of premorbid BMIs throughout childhood and adolescence. The 
opportunity to integrate these data with subsequent eating disordered symptomatology at 
treatment intake offers the potential for a prospective analysis of the relationship between 
premorbid weight variables and later clinical characteristics and outcome. Analysis of 
premorbid weight trajectory and its associations with symptoms at treatment presentation 
will afford us the opportunity to test premorbid body weight as a factor relevant to eating 
pathology. Findings from the current study may also substantiate the need for increased 
emphasis on body weight in future eating disorder research and conceptualizations.  
The current study is part of a joint project, wherein another doctoral student and I 
are examining the relation between premorbid BMIs and eating disorder characteristics 
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but are focusing on different groups of these characteristics.  As such, each project 
examines distinct outcomes. The current project is focused primarily on the relationship 
between premorbid body weights and restrictive eating symptoms and weight and shape 
concerns across patients of all diagnoses. Binge/purge related symptom severity has been 
examined separately in another project and as such will not be addressed henceforth. 
Classification of psychological symptoms and disorders has historically followed 
a categorical framework, such that  presenting symptoms have traditionally informed a 
decision to assign an individual to a specific diagnostic group (e.g., AN vs BN). Indeed, 
these categorical diagnoses allow for an efficient classification system which has guided 
treatment and research decisions for decades.  However, in recent years, the field of 
psychology has witnessed increased emphasis on dimensional frameworks of 
psychological disorders, which identify domains or constructs relevant to functioning and 
assess these on a continuum from “normal” to “abnormal”.  Dimensional classification of 
domains thereby measures individual variability in functioning and can elucidate 
differential patterns of symptom severity. Dimensional frameworks of psychological 
disorders and symptoms have been espoused by the American Psychological Association, 
U.S. National Institutes of Health, and World Health Organization (Insel et al., 2010; 
Regier, 2007). An example of such a dimensional framework is the National Institute of 
Mental Health’s (NIMH) Research Domain Criteria (RDoC) initiative, which identifies 
constructs that can be measured continuously (e.g., attention) and that contribute to 
broader domains of functioning (e.g., cognitive systems).  
  Given the field’s recommendations and because the current project is exploratory 
in nature, the current study sought to examine the relationship between premorbid body 
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weights and eating pathology using primarily dimensional constructs that are relevant 
across traditional categorical diagnoses (e.g., dietary restraint as an eating disordered 
behavior identified in both AN and BN patients) to identify specific symptom clusters 
associated with premorbid body weights. Although the framework for the current project 
was primarily dimensional, different eating disorder diagnoses have different ages of 
onset and may therefore be differentially associated with premorbid weight status and 
symptom severity. As such, diagnoses were considered in the secondary aims of the 
study, described below. 
1.5. Aims and Hypotheses 
 
As aforementioned, the current study was exploratory and designed to elucidate 
relatively uninvestigated relationships. Findings from current research suggest eating 
disorder patients may be susceptible to higher premorbid weights, and that premorbid 
weights may be relevant to eating disorder development and outcome. With respect to 
these findings, the current study sought to examine the relationship between premorbid 
body weights and clinical outcome, as measured by severity of eating pathology spanning 
a range of symptoms.  
 
Primary Hypothesis: Relationship between premorbid BMI and clinical outcomes 
Current findings with regard to relationships between premorbid BMIs and clinical 
outcomes suggest potentially positive associations between the two. For example, given 
the notion that eating disordered individuals have a strong desire to be thin, it stands to 
reason that the further away from an ideal body weight these individuals are (i.e., the 
higher their weight), the greater the pressure to engage in eating disordered behaviors. 
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Moreover, elevated weight is itself a predictor of accelerated weight gain in the future, 
leaving eating disordered individuals at the continued mercy of their eating disordered 
behaviors to counteract drives for weight gain. Higher premorbid body weights may 
therefore be relevant to symptom development (i.e., weight loss from an undesired higher 
weight) and maintenance (i.e., struggle to prevent a return to the higher weight). 
Preliminary research provides support for this notion: findings provide support for the 
potential relationship between elevated premorbid BMIs and increased eating-disorder 
related symptoms typically associated with AN symptoms, including Restrained Eating, 
Eating Concerns and Weight and Shape concerns (Garfinkel et al., 1980; Sawyer et al., 
2016; Shinder & Shephard, 1993). As such, we expect elevated premorbid BMI 
measurements to predict greater symptom severity at intake.  
Specific Primary Aim: To investigate whether premorbid body weights are 
associated with subsequent severity of symptoms (including Restrained Eating, 
Eating Concerns, and Shape and Weight concerns) at treatment intake. 
Relationship between premorbid weights and current weight status 
Available evidence suggests potential relationships between premorbid BMI and 
subsequent clinical outcomes. However, we recognize that there may be an additional 
relationship between premorbid weights and current weight status (i.e., current BMI and 
current WS). For instance, as discussed above, research supports the notion that BMI 
“tracks” over time, implicating a relationship between premorbid body weights and 
current body weight. Moreover, given the pressures of avoiding weight gain, elevated 
premorbid weights may also motivate patients to keep their current weight far below 
premorbid levels. Indeed, this notion is consistent with findings that AN patients with 
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higher premorbid levels lost more weight before entering treatment (Coners et al., 1999). 
As such, premorbid weight may be associated with current BMI and levels of WS (i.e., 
sustained weight loss). BMI and WS were therefore considered as possible covariates to 
include in primary analyses.  
Secondary Analysis: Relationship between premorbid weight, age of onset, and 
diagnosis 
  It is well known that there is a difference in the average age of onset between AN 
and BN patients, with AN patients developing their disorder at an earlier age (Favaro, 
Caregaro, Tenconi, Bosello, & Santonastaso, 2009). If AN patients do have an earlier age 
of onset than BN patients, it is plausible that disorder development at an earlier age may 
contribute to lower premorbid weights, and may therefore partly explain relationships 
between premorbid weight and clinical outcome. Given that both diagnosis and age of 
onset are collected by Renfrew, the current study sought to examine whether AN and BN 
patients differed in premorbid BMIs, and whether age of onset explained some of this 
difference.  
 Secondary Aim: To 1) confirm that prior findings with regard to differential age 
of onset for AN and BN, and 2) determine whether premorbid BMIs differ in AN 
and BN patients (and if so, whether the difference is partly explained by different 
ages of onset). 
Chapter 2: Methods 
2.1 Participants  
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 The current study included female adolescent and adult inpatients who received 
residential treatment services from The Renfrew Center Eating Disorder Treatment 
Facility Spring Lane (Philadelphia, PA) and Coconut Creek (Coconut Creek, FL) 
locations. All inpatients received treatment between February 2015 and August 2016 and 
were either currently receiving treatment or had recently discharged. De-identified data 
from patients’ growth charts, intake assessments and weight data were collected from 
patients and included in analyses. 
2.1.1 Recruitment 
 
  Growth charts were collected between September 2015 and December 2016.  All 
participants were at least 14 years of age and were current or previous inpatients who 
received residential treatment from Renfrew’s Spring Lane or Coconut Creek locations.  
 During this time, all patients at Renfrew were asked to complete three assessment 
surveys, including one at intake, one at discharge, and one at six-month follow-up.  All 
assessment surveys were self-report measures administered either online or in paper 
format, and were comprised of questions designed to measure eating pathology, mood 
and anxiety, and individuals’ experience in treatment at Renfrew. Patients who completed 
all three assessments (and responded to at least 90% of their follow-up assessment items) 
were given a $30 Amazon gift card to compensate them for their time. Because the 
current study utilized de-identified data that had already been collected by Renfrew, no 
additional compensation was offered for the current study.  
2.1.2. Inclusion and exclusion criteria 
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To be included in analyses, participants were required to: 1) provide prior consent 
to use patient-provided data for external research purposes (consent provided by the 
patient, if adult, or by her parent(s) or legal guardian(s), if adolescent), and 2) have 
growth charts with a minimum of one BMI data point prior to the onset of the eating 
disorder. 
2.2 Procedures 
 
 Growth chart data were requested by Renfrew for all patients 23 years old and 
younger at admission. If growth chart data were not collected from these patients at 
admission, follow-up requests for growth charts were made for patients who were 1) 
significantly low weight, 2) significantly high weight, or 3) highly weight suppressed 
(i.e., great than 15 lbs). Growth chart data were also requested for certain patients above 
23 years in the event that the patient was insistent that she should be a lower weight.  
  Intake and discharge assessment and weight data were collected by the research 
team at both Renfrew Center locations for the majority of patients. Every 6-8 weeks, 
Renfrew research team members reviewed patient data for inpatients who had been 
admitted over the past month. Patients who consented to using data for research purposes 
received a unique identifying participant code, which was used to label their data. Data 
from these patients were then collected, de-identified, labeled and shared with Drexel 
study team members according to procedures detailed below.   
2.2.1. Growth Charts 
 
 Growth charts for eligible inpatients were de-identified and labeled with 
participant code by Renfrew’s research team members. De-identified growth charts were 
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then scanned and e-mailed to the current study team members. Data from growth charts 
were subsequently cleaned and entered according to the procedures described below (see 
Section 2.5, Data Analysis). 
2.2.2. Assessment Data 
 
  The Renfrew research team maintains a research database with all intake 
assessment, discharge assessment, and weight data for all patients. Research team 
members selected eligible participants from this larger database and transferred their de-
identified information to a new database. Data were then labeled using participant codes 
assigned to each patient, and the updated database was shared with study team members.  
  Data included in the updated, de-identified database were cleaned by study team 
members according to the procedures described below and were then combined with 
growth chart data for subsequent analyses (see Section 2.6, Data Analysis).  
2.3 Measures 
 
Because the current study sought to prospectively examine relationships using 
data already collected, specific instruments used to measure constructs of interest were 
not selected by study team members. Although there may be more ideal measures to 
consider for the purposes of the present study, the measures described below were 
selected based on study aims and data available to the research team. 
2.3.1. Weight Measures   
 
Growth Charts: Growth charts were provided by patients’ pediatricians and primary care 
physicians. The growth charts included records of patients’ measured height, weight, and 
occasionally BMI at a series of ages, and were used to calculate two different 
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measurements of premorbid BMI, described below (see Section 2.5.2, Data Cleaning). 
The data provided in the growth charts were subject to a number of inherent limitations 
(see Section 2.5.1, Limitations of Data). As such, a series of guidelines were developed to 
ensure consistent and reliable cleaning and coding of data to minimize this variability. 
See Section 2.5.2 (Data Cleaning) for specific cleaning and coding procedures. 
To adjust BMI relative to age, all BMI values were converted to z-scores 
according to the Center for Disease Control and Prevention (CDC) growth charts. 
Because premorbid body weight is not an extensively researched or clearly defined 
construct, we calculated the following two measurements of premorbid BMI. See Figure 
1 for an illustration of each of these values using a sample growth chart. 
1. Premorbid BMI Measurement #1, Highest premorbid BMI: Highest premorbid z-
BMI is of interest because it represents the extent of elevated BMI reached prior to 
disorder development and therefore reflects a general proneness toward reaching 
higher BMI levels. See Figure 1, point B for an illustration of this variable. 
2. Premorbid BMI Measurement #2: Trajectory to highest BMI: Trajectory to highest 
premorbid z- BMI provides additional information on one’s weight prior to 
reaching their highest premorbid BMI and may therefore be informative 
independently of highest premorbid BMI alone. This measurement is defined as the 
slope between the highest premorbid z-BMI and its penultimate premorbid z-BMI. 
In Figure 1, this variable would be measured by calculating the slope between 
points A and B.  
Current BMI: Renfrew staff measured participants’ height and weight at both intake and 
discharge.  
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Weight Suppression: Weight suppression was calculated as the difference between the 
patient’s self-reported highest ever adult weight and patient’s weight taken at admission.  
2.3.2. Eating Disorder Diagnosis and Symptoms  
 
Eating Disorders Examination Questionnaire Version 5.2 (Fairburn & Beglin, 2008) 
(EDE-Q) 5.2: The EDE-Q is a 31-item self-report version of the Eating Disorders 
Examination structured interview, and is used to measure the severity and frequency of 
symptoms associated with eating pathology over the previous 4 weeks (28 days). EDE-Q 
scores are calculated according to a global score (based on all items), and specific 
subscale scores (Restraint, Eating Concerns, Weight Concerns, and Shape Concerns). The 
EDE-Q has demonstrated reliability for the total scale and four subscales (Peterson et al., 
2007). 
Age of Onset: Renfrew’s intake assessment questionnaire asks patients to self-report the 
age at which they developed eating disorder-related symptoms (“at what age did your 
eating disorder first begin?”). Patient response was used as age of eating disorder onset. 
Diagnosis. Renfrew psychiatrists assessed and assigned an eating disorder diagnosis to all 
patients at intake.  
2.4 Ethical Considerations 
 
 The current study fell under a blanket protocol approved by Drexel University’s 
Institutional Review Board. All participants included in the study provided informed 
consent to have their data used for research purposes. As described above, all participant 
data were de-identified by Renfrew staff and labeled with a non-identifying participant 
code before being shared with Drexel study team members. Therefore, Drexel study team 
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members did not have access to participants’ identifying information and were not be 
able to link collected data with names. The design of the study also precluded direct 
contact between participants and study team members, thereby significantly minimizing 
the likelihood of risks or adverse events. No risk or adverse events were noted.  
2.5 Data Preparation 
2.5.1 Limitations of Data 
 
As mentioned above, growth chart data have certain inherent limitations. For one, 
data were recorded most frequently as points on a graph (i.e., a dot at a point representing 
height and weight) and were only rarely recorded as specific values (i.e., “121.3 lbs”). As 
such, in the absence of specific values, data required visual inspection and were 
estimated, leaving the possibility for some error inherent in this process. Moreover, 
changes in height and weight were recorded at variable time points both within and 
between participants, such that some patients had numerous data points (e.g., more than 
10), while others had very few (e.g., 1 or 2). Additionally, within patients, the time 
between data points varied significantly depending on the frequency of their past medical 
visits. Finally, the number of data points collected prior to the onset of a patient’s eating 
disorder was also highly variable. Because growth chart data were highly variable both 
within and between participants, efforts were made to clean and organize the data for 
analysis purposes. Study team members responsible for data cleaning and entry were 
trained according to study protocol. Specific procedures for each measure provided are 
included below.   
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2.5.2. Data Cleaning  
 
Data Entry 
The occasionally inconsistent nature of the growth chart data required 
standardized coding efforts to maximize accuracy and reliability of the data entered. Two 
Drexel study team members reviewed the initial batch of collected growth charts to 
identify all possible ambiguities and develop a standardized set of rules to guide data 
entry decisions, as detailed in Table 1. The first ten growth charts were entered jointly by 
both study team members according to these guidelines. The subsequent ten growth 
charts were entered independently by the same study team members and compared to 
determine inter-rater reliability.  
Data Organization 
Once all data were entered, study team members ensured that all participants had 
height and weight data in centimeters and kilograms, respectively. For participants whose 
growth charts did not include BMI data, height and weight values were used to determine 
BMI values in kg/m2.  
All growth chart data were then combined with all other variables (EDE-Q, age of 
onset, current BMI, WS) in a master database. Age of disorder onset was used to 
distinguish premorbid BMIs from BMIs recorded after disorder development. All BMI 
values were converted to z-scores according to the Center for Disease Control and 
Prevention (CDC) growth charts. We then calculated the two measurements of premorbid 
BMI listed above.  
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Chapter 3: Data Analysis  
All analyses were conducted in SPSS v. 23.0. After establishing rules for data entry, 10 
growth charts were entered independently by two raters and checked for reliability. Premorbid 
weight data between two raters demonstrated excellent inter-rater reliability across datapoints, 
rage = 1.0, rweight = .99, rstature = .98. Once reliability was confirmed, remaining premorbid 
weight data were entered by both raters. 
Growth chart data were collected from a total of 101 female participants. Of the 
data collected, 41 participants with both viable weight data collected prior to self-
reported eating disorder onset and completed intake assessment data were available for 
analyses. Approximately half of these participants (n =21) had enough weight data to 
calculate weight trajectory to highest premorbid z-BMI. Due to the small sample size, 
weight trajectory to highest premorbid z-BMI was not included in analyses.   
Descriptive statistics were generated for all study variables. A one-way analysis 
of variance (ANOVA) was employed to compare weight data, eating disorder symptoms, 
and age of onset across different diagnoses. Relationships between highest premorbid z-
BMI and current weight variables (WS and BMI at admission) were assessed using two-
tailed Pearson correlation analyses. Across all weight variables, BMI measurement #1 
(highest premorbid z-BMI) was significantly positively correlated with admission BMI, r 
= .570, p < .001. This relationship was expected due to prior findings with regard to BMI 
tracking over time (Steinhausen et al., 2009). There were no other significant associations 
between variables (see Table 2).   
The effects of highest premorbid z-BMI on current eating disorder symptom 
severity were assessed using multiple linear regression. Assumptions for multiple linear 
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regression were tested, including the absence of influential outliers, normal error 
distribution, absence of multicollinearity, and homoscedasticity.  Highest premorbid z-
BMI was first individually entered into a regression as a measure of the independent 
effects on eating disorder symptoms.  
Chapter 4: Results 
Descriptive Statistics 
  The final sample consisted of 41 female participants aged 14 to 43 (Mage = 17.27, 
SDage = 4.79). Across all participants, BMI at admission ranged from 11.8 to 44.1 (MBMI 
= 19.74, SDBMI = 6.69). Self-reported disorder onset occurred during adolescence for all 
participants (Mage = 13.61, SDage = 1.76, rangeage = 10-18).  Highest premorbid z-BMIs 
ranged from -1.6 to 2.5 across participants (Mz-BMI = 0.66, SDz-BMI = 0.96). See Table 3 
for descriptive statatistics for EDE-Q scores on Eating Concerns, Weight concerns, Shape 
Concerns, and Restrained Eating behaviors.  
Eating Disorder Diagnoses 
  Eating disorder diagnosis was unavailable for one participant. Of the remaining 
40 participants, 18 (45%) met criteria for a diagnosis of AN-R, 10 (25%) for BN, 7 
(~18%) for atypical AN, and 5 (~13%) for AN-B/P. Results of the one-way ANOVA 
between these four groups indicated a significant difference in age of onset, F(3,36) = 
3.04, p = .04, weight variables (highest premorbid z-BMI, F(3,36) = 3.41, p = .03, BMI at 
admission, F(3,36) = 11.28, p < .001), and one of the four eating disorder subscales 
measured by the EDE-Q (Eating Concern subscale scores, F(3,36) = 2.94, p = .046). 
There was also a trending difference in self-reported EDE-Q Weight Concern,  F(3,36) = 
2.428, p = .08. It is noted that the small sample sizes of each group limit the validity of 
29 
 
any apparently meaningful differences. Results from Tukey post hoc analyses are 
discussed in detail below.  
 Age of Onset 
  Tukey post hoc tests revealed that the atypical AN group had a significantly 
earlier age of onset (12.14 + 1.68) than those with AN-R (14.23 + 1.98). There were no 
statistically significant differences in age of onset between any other group. 
Weight Variables 
  Tukey post hoc analyses revealed significantly higher premorbid z-BMI in 
patients diagnosed with BN (1.42 + 1.99) as compared to those with AN-R (mean = 0. 
19+.54, p = .03) and atypical AN (.26 + .96, p = .05). Similarly, BMI at admission was 
significantly higher among BN patients (27.41 + 9.49) than AN-R (16.14 + 1.96, p < 
.001), AN-B/P (17.24 + 1.18, p = .004) and atypical AN (20.54 + 1.14, p = .04). There 
were no significant differences in either weight variable between AN subtypes. 
Eating Disorder Symptoms 
  Post hoc tests revealed marginally greater self-reported Eating Concerns (EDE-Q 
Eating Concern subscale score) in BN patients (4.62 + .93) than in AN-R patients (3.47 + 
1.29, p = .06). No additional significant group differences in Eating Concern or Weight 
Concern scores were detected between any groups. 
Single-Variable Effects of Highest Premorbid Weight  
  Results of linear regression analyses indicated that when entered independently 
into the model, higher premorbid z-BMIs accounted for a significant amount of 
variability in EDE-Q Eating Concern scores at intake, R2=.11, F(1,39) = 4.69, p = .04, 
suggesting that those with higher premorbid weights are susceptible to higher Eating 
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Concerns at admission. Highest premorbid z-BMI did not significantly predict EDE-Q 
Weight Concern, Shape Concern or Restraint. See Table 4 for paramaters of each 
regression. 
Effect of Highest Premorbid Weight and Covariates 
To examine the effects of highest premorbid z-BMI with relevant covariates, 
including age at highest premorbid z-BMI and BMI at admission, subsequent linear 
regression analyses were run to determine whether highest premorbid z-BMI explained a 
significant amount of variance in EDE-Q Eating Concern scores with inclusion of these 
covariates.  Overall, the model explained a significant amount of variability in EDE-Q 
Eating Concern scores at intake, F(3,37) = 3.94, R2=.20, p = .039. However, higher 
premorbid z-BMI no longer predicted Eating Concern scores, B = .13, SE(b) = .24. p = 
.58, r2 = .007. Instead, results suggest that BMI emerged as the only predictor of Eating 
Concerns, B = .07, SE(B) = .77. p = .046, r2 = .09. Age at highest premorbid z-BMI did 
not significantly predict Eating Concerns, B = -.02, SE(B) = .05, p = .58, r2 = .004 (see 
Table 5). 
Exploratory Analyses 
  Additional exploratory linear regression analyses were run to examine the 
possible interaction between highest premorbid z-BMI and BMI at admission. First, both 
variables were centered and their product term was computed; centered variables and 
their product term were then entered as predictors of each of the four eating disorder 
symptom severity scores.  
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 Table 5 lists the parameters of these regression analyses. Overall, the model with 
both variables and their interaction term significantly predicted EDE-Q Eating Concerns, 
F(3,37) = 4.35, R2 = .26, p = .01. There was a main effect of BMI at admission, B = .155, 
SE(B) = .06, p = .01, r2 = .14, such that higher BMI was associated with higher Eating 
Concern at admission. There was no significant main effect of highest premorbid z-BMI, 
B = .08, SE(B) = .23, p = .74, r2 = .002. There was a marginally significant interaction 
between highest premorbid z-BMI and BMI at admission, B interaction = 1.07, SE(B) = 
.04, p = .08, r2 = .06. Specifically, this interaction indicated that a higher BMI at 
admission combined with a history of relatively lower highest premorbid weight 
predicted greatest Eating Concerns at admission. To better understand these interaction 
patterns, we divided all patients into 2 admission BMI groups (high vs. low) and 2 
premorbid z-BMI groups (high vs. low) to compare EDE-Q Eating Concern scores.  
See Figure 2 for an illustration of this relationship.  
  Regression analyses yielded similar results for the EDE-Q Weight Concern 
scores, F(3, 37) = 4.83, R2 = .28, p = .006. There was again a main effect of BMI at 
admission, such that higher BMI was associated with higher Weight Concern scores at 
admission, B = .24, SE(B) = .07, p = .002, r2 = .22. There was no main effect of highest 
premorbid z-BMI, B = -.45, SE(B) = .28, p = .116, r2 = .05. There was a marginally 
significant interaction between highest premorbid z-BMI and BMI at admission, B 
interaction = -.09, SE(b) = .048, p = .056, r2 = .07. The pattern of these findings was 
consistent with Eating Concern results: Weight Concern was greatest among those with 
both higher BMI at admission and a history of relatively lower highest premorbid z-BMIs 
(see Figure 3). 
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 To better understand the interaction between current and historical weight, we 
also compared mean weight variables between the four groups. See Table 7 for mean 
values of admission BMI and highest premorbid z-BMI across groups.  
 Regression analyses were run again to control for age at highest premorbid z-BMI 
as a possible covariate. These analyses did not change results; see Table 6 for parameter 
estimates from both regression analyses. 
4.1. Power Analysis 
 
  An initial power analysis was conducted prior to data collection using G*power 
(Faul, Erdfelder, Lang, & Buchner, 2007). Input parameters included alpha level (.05), 
power (.80), and effect size (.15). Effect size was set to medium due to the primarily 
exploratory nature of the analyses. Results indicated that for the primary hypothesis, the 
current study required a sample size of 68 participants. The sample size of the current 
study largely depended on the number of patients who both provided sufficient data and 
consented to share these data for research purposes. With only 41 total participants 
included in the analyses, the current study was underpowered. Limited power is discussed 
and considered as a potential study limitation below.  
Chapter 5: Discussion 
  In considering the results of the current study, it should be noted that several 
factors create interpretive challenges. These limitations will be detailed and addressed 
throughout the discussion.   
  Although there was a significant difference in premorbid z-BMIs between AN 
and BN patients, there was not a significant difference in the age of onset between these 
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patient groups, suggesting that earlier age of onset did not necessarily account for 
differences in premorbid weight. As such, all patients were included and considered in 
the same analyses.  
 To confirm the accuracy of growth chart weights, we ran a correlation between 
highest premorbid z-BMI and self-reported highest past weight prior to disorder onset. A 
significant correlation between the two variables (r = .47, p = .005) suggest the highest 
premorbid z-BMIs as collected by growth charts were correlated with patients’ reported 
highest past weight, and are therefore further corroborated.  
On average, highest premorbid z-BMI across participants was 0.66, suggesting 
higher than average weights premorbidly; this result replicates past findings about those 
with eating disorders having relatively elevated premorbid BMIs (Crisp et al., 1980). 
However, because the current analysis did not include a control group, it is not certain 
that elevated z-BMIs in the current sample were necessarily due to an eating disorder 
diagnosis. Consistent with study hypotheses, initial results indicated that among female 
eating disorder inpatients, highest premorbid z-BMI was associated with greater Eating 
Concerns at treatment admission. Moreover, there was a medium effect size of this 
relationship, suggesting a potentially significant relationship. 
However, in the presence of other variables, including BMI at admission and age at 
highest premorbid z-BMI, highest premorbid z-BMI was no longer independently 
associated with any eating disorder symptoms. Instead, BMI at admission emerged as the 
strongest predictor of Eating Concerns. Taken together, these findings were inconsistent 
with our hypotheses that individual differneces in highest premorbid BMI have lingering 
effects that continue to influence body dissatisfaction and eating pathology. Findings 
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instead suggest that BMI at admission, or current BMI, better accounted for variability 
across eating disorder symptoms than highest premorbid BMI. It is noted that although 
multicollinearity does not affect overall model results, the substantial correlation between 
admission BMI and highest premorbid z-BMI suggests that coefficient estimates for 
individual predictors may be unstable or invalid. As such, it is difficult to draw definitive 
conclusions that highest premorbid z-BMI is not independently important when including 
admission BMI. Interestingly, exploratory analyses examining the combined influence of 
highest premorbid z-BMI and BMI at admission suggested a potential interaction 
between historical and current weight. Overall, individuals at higher current BMIs tended 
toward increased Eating and Weight concerns. However, among these individuals, those 
with an added history of relatively lower premorbid weights exhibited the greatest Eating 
and Weight concerns.  
  These initial findings run counter to our original hypotheses, in that lower 
premorbid weight was associated with greater eating disorder symptoms later on. 
However, these findings potentially capture an unexpected relationship between current 
and historical weight. Based on initial hypotheses, the original expectation would be that 
those with high historical and current weights would have the greatest Eating and Weight 
Concerns. However, the observed results suggest that a more powerful effect is 
associated with having a high current weight that is relatively elevated compared to 
premorbid weights, so that perhaps such individuals are mostly concerned with the 
prospect of reaching or exceeding their highest ever weight. On the other hand, 
individuals who had historically higher premorbid weights may evaluate their current 
weights relative to their historical weights. It is possible that despite being at a relatively 
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higher current BMI, they remain further below their highest premorbid weight and are, in 
turn, relatively less distressed. Moreover, despite being only marginally significant, these 
interactions both had small-medium effect sizes, indicating that lack of a significant 
interaction may have been due to the small sample size rather than a non-significant 
relationship. Perhaps, then, the role of historical weight and premorbid BMI is indeed an 
important measure of eating disorder severity, but one which should be carefully 
considered in light of current weight status, which undoubtedly influences current eating 
disorder symptom severity. Indeed, individuals with relatively lower premorbid weights 
could evaluate their current weight as too close to their historical highest weight and 
respond accordingly.  
  It is noted that these findings should be considered as highly tentative, given a 
number of limitations that are discussed below. 
Limitations and Future Directions 
 In considering the findings of the current study, it is important to address a 
number of inherent limitations. For one, as aforementioned, there was significant 
variability in the premorbid weight data, with differences in both number of data points, 
time between data points, and age at which weights were taken. Importantly, a number of 
participants whose growth charts were available had switched physicians throughout 
adolescence and did not have weight data prior to disorder development. Therefore, 
despite collecting data from over 100 participants, only a limited number of individuals 
had data available for analyses, resulting in a small sample size that limited the power of 
the study and the likelihood of detecting true differences. Similarly, weight data needed 
to calculate other premorbid BMI variables were often not available, which reduced the 
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sample size for certain planned analyses too much for meaningful interpretation. Data 
used in analyses allowed for calculation of highest premorbid z-BMI, but were not 
thorough enough to examine the relationships between other premorbid weight 
measurements, such as trajectory to highest weight, first available, z-BMI, or earliest to 
highest weight change, and eating disorder symptom severity at admission. 
 Moreover, because follow-up requests for growth chart data were made for 
participants with specific weight concerns, it is possible that the data collected were more 
representative of a specific sub-sample of participants than the general inpatient 
population. As such, this method of collection should be considered as a potential study 
limitation.  
 We also acknowledge that because these analyses were exploratory, we did not 
correct for multiple comparisons. As such, it is possible that certain findings would lose 
significance by controlling for comparisons, and this should be taken into consideration 
when interpreting the current results. Moreover, as aforementioned, the strong correlation 
between admission BMI and highest premorbid z-BMI limits the interpretation of the 
coefficient estimates for the individual predictors.  
  Another limitation to consider is the lack of information about psychiatric history 
across patients. Despite having access to current diagnoses, history of prior eating 
disorders was not collected; as such, it is possible that certain BN patients had previously 
had an AN diagnosis, which could explain the unexpected earlier age of self-reported 
symptom onset among BN patients. Similarly, the current analyses did not examine 
comorbidities or current medication use, which could have plausibly influenced results. 
  Additionally, there are certain limitations to the measures employed in the study. 
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The current study’s estimate of highest premorbid z-BMI was defined by the highest 
available z-BMI prior to eating disorder onset. As such, although this measurement was 
correlated with self-reported highest past weight and used as an index of highest 
premorbid z-BMI, it is plausible that higher premorbid weights were reached but not 
recorded or included in available growth charts. More specific and consistent growth 
chart data may have enabled us to better examine the role of historical weight. There are 
additional limitations to the outcome measures utilized. For example, the current gold 
standard for measurement of eating disorder psychopathology is the EDE clinician 
administered interview (Guest, 2000). However, the current measure of eating disorder 
symptom severity utilized a readily available version of the EDE-Q measure already 
distributed to patients at Renfrew; as such, study outcome variables were measured using 
subjective, self-reported severity rather than clinician calculations of severity. It is 
therefore possible that use of the self-report EDE-Q might have introduced error in the 
results.    
Similarly, because age of onset is based on self-report in response to a written 
question, it is subject to different interpretation (e.g., time of symptom onset vs. weight 
loss vs. official disorder diagnosis). The ambiguity of this question limits our ability to 
confirm age of disorder onset, and is therefore noted as a potential study limitation. 
  It is also noted that certain eating disorder patients, particularly those who were 
low weight at admission, may have been content with their body weight, and may 
therefore not have endorsed high weight concerns. As such, Weight Concern subscale 
scores may not adequately reflect current symptom severity among these patients and 
should be considered as a limitation of the current study.  
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  Finally, it is noted that the current study examined individuals in an inpatient 
setting. Given that a number of variables may differ between patients identified in 
inpatient settings versus patients in other outpatient or community settings, it is 
impossible to generalize our findings to all eating disorder participants.  
  Taken together, findings from the current study suggest a combined influence of 
historical and current weight on eating disorder symptom severity. Based on the available 
data, it appears that while the information gleaned from one’s historical weight and 
current weight are independently important, an understanding of both variables together 
helps one to better understand one’s evaluation of their current weight. However, as 
aforementioned, the current study presented a number of unexpected challenges which 
significantly limit interpretation of findings. Therefore, it is still plausible that a more 
methodologically adequate study could perhaps reveal a role for historical highest BMIs.  
For example, similar data could be pursued in other countries where high quality growth 
chart data are kept on citizens across the lifespan. Future research studies could use these 
data to better test the relevant hypothees. Moreover, these same data could also be 
employed to further examine the potential independent and interacting effects of 
historical and current BMI, which would allow for a better understanding of the role of 
body weight in eating disorder symptomatology.  
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Appendix B: Tables 
 
 
 
Table 1. Guidelines for Entering Growth Chart Data. 
1. When growth chart data include both points on a graph and numerical values representing weight, height or BMI at a given time-point, enter exact numerical 
values. 
 
2. When growth chart data only include points on a graph, adhere to the following guidelines when deciding what numerical values the points represent: 
a. Round age to nearest quarter year (e.g., 15, 15.25, 15.5, 15.75, or 16). 
b. Round height to nearest whole centimeter.  
c. Round weight to nearest whole kilogram. 
d. Round BMI values to nearest tenth (e.g., 18.1, 18.2, 18.3) 
 
2a) When nearest datapoint to round to is unclear or ambiguous: 
a) if dot is between two lines and touches or crosses one line but not the other, choose the value of the line it touches/crosses. 
b) if dot is in between two lines and touches or crosses both lines, determine what line the greater portion of the dot touches or crosses, and choose the 
value of that line. 
c) if dot is between two points and does not touch or cross either line, first round up to nearest quarter year, whole centimeter, whole kilogram, or tenth of 
a BMI unit. 
e. Note! If dot is not touching line, it is unlikely that the line’s value was meant by the physician. Therefore, if rounding up means you will be entering 
the line’s value, round down. 
2b) When a number of datapoints are graphed for a given age, first enter data according to the following guidelines and then make note of the participant for 
later discussion with study team: 
a) Select height and weight datapoints that were recorded nearest to every quarter year (if multiple dots near quarter year, pick the dot closest). 
b) If datapoints corresponding to quarter years are too difficult to determine (e.g., too many datapoints, too close to one another), select height and weight 
datapoints that were recorded nearest to every half year 
c) If datapoints corresponding to half years are too difficult to determine, select height and weight datapoints that were recorded nearest to every whole 
year. 
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Table 2. Correlations Between Premorbid and Current Weight Variables. 
Variable Mean (SD) N 
Highest premorbid z-
BMI 
Trajectory to highest 
premorbid z-BMI 
Admission BMI Admission WS 
Highest premorbid z-BMI .66 (.96) 41 --    
Trajectory to highest 
premorbid z-BMI 
.31 (.45) 27 -.226 --   
Admission BMI 19.74 (6.70) 41 .570** -.235 --  
Admission WS 18.70 (6.21) 34 -.044 -.244 -.265 -- 
**p < .001 
 
 
 
Table 3. EDE-Q Subscale Scores. 
Subscale Mean SD Range 
Eating Concerns 3.80 1.24 .60-5.80 
Weight Concerns 4.29 1.53 .20-6.00 
Shape Concerns 4.90 1.33 .88-6.00 
Restraint 3.67 1.66 .00-6.00 
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Table 4. Highest Premorbid z-BMI Parameter Estimates Predicting EDE Subscale Scores. 
 Eating Concerns Weight Concerns Shape Concerns Restraint 
 
B SE(B) r2 p B SE(B) r2 P B SE(B) r2 p B SE(B) r2 P 
Intercept 
3.52 .23  <.001 4.19 .29 -- <.001 4.79 .26  -- 3.86 .32  <.001 
Highest 
premorbid z-
BMI 
.43 .20 .107 .037 .15 .26 .01 .56 .163 .22 .01 .47 -.29 .27 .03 .30 
 
 
 
Table 5. Parameter Estimates Predicting EDE-Q Eating Concern Scores Using Highest Premorbid z-BMI and Covariates. 
 
 Eating Concerns 
 B SE(B) r2 p 
Intercept 2.49 .68  .001 
Highest premorbid z-BMI .13 .24 .01 .58 
Age at highest premorbid z-BMI -.02 .05 .003 ..68 
BMI at admission .07 .04 .09 .046 
  
5
0
 
Table 6. Parameter Estimates Predicting EDE-Q Subscale Scores Using Interaction between Highest Premorbid z-BMI and BMI at 
Admission. (a) Without Controlling for Age at Highest Premorbid z-BMI. (b) While Controlling for Age at Highest Premorbid z-BMI. 
Table 6(a)                  
Variable Eating Concerns Weight Concerns Shape Concerns Restraint 
 B SE r2 p B SE r2 p B SE r2 p B SE r2 P 
Intercept 4.04 .22  <.001 4.62 .27  <.001 5.14 .26  <.001 3.90 .34  <.001 
Highest 
premorbid 
z-BMI 
.08 .23 .002 .74 -.45 .28 .05 .116 -.17 .26 .02 .533 -.28 .34 .02 .42 
BMI at 
admission 
.16 .06 .14 .01 .07 .07 .23 .002 .15 .07 .11 .04 .06 .09 .01 .51 
Highest 
premorbid 
x BMI 
admission 
-.07 .04 .06 .08 -.09 .05 .09 .056 -.07 .05 .05 .14 -.06 .06 .03 .30 
 
Table 6(b) 
 \               
Variable Eating Concerns Weight Concerns Shape Concerns Restraint 
 B SE r2 p B SE r2 p B SE r2 P B SE r2 P 
Intercept 4.04 .23  <.001 4.60 .26  <.001 5.13 .26  <.001 3.883 .34  <.001 
Highest 
premorbid z-
BMI 
.06 .24 .001 .80 -.56 .28 .07 .05 -.21 .27 .01 .46 -.366 .35 .03 .30 
BMI at 
admission 
.16 .06 .14 .01 .26 .07 .25 .001 .15 .07 .12 .03 .07 .09 .02 .43 
  
5
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Table 7. Mean Weight Values Across Groups.  
 Low-Low1
 
Low-High2 High-Low3 High-High4 
BMI admission 14.93 16.03 19.27 25.06 
Highest premorbid z-BMI -0.19 1.16 -0.09 1.55 
1Low-Low = low admission BMI and lower highest premorbid z-BMI 
2Low-High = low admission BMI and higher highest premorbid z-BMI  
3High-Low = high admission BMI and lower highest premorbid z-BMI 
4High-High = high admission BMI and higher highest premorbid z-BMI 
 
 
 
 
Table 6(b) continued 
Age at 
highest 
premorbid z-
BMI 
-.02 .05 .002 .744 -.11 .06 .06 .08 -.04 .06 .01 .52 -.08 .08 .03 .28 
Highest 
premorbid x 
BMI 
admission 
-.07 .04 .06 .088 -.09 .05 .07 .06 -.07 .05 .05 .16 -.06 .06 .03 .32 
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Appendix C: Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Sample Growth Chart Data. Premorbid BMI measurements calculated as: 1) Highest premorbid z-BMI (B); 2) Trajectory to 
highest premorbid z-BMI (slope of point A to point B). For initial analyses, regressions testing hypothesis 1 included measurements 
1 + 2 as predictors.  
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Figure 2. EDE-Q Eating Concerns Predicted by Highest Premorbid z-BMI x BMI at Admission. 
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Figure 3. EDE-Q Weight Concerns Predicted by Highest Premorbid z-BMI x BMI at Admission. 
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